Andreas Gaumann, a holder or the M.D. degree, finished studies in physics in 1990 and in medicine in 1996 from the Johannes Gutenberg University of Mainz, Germany. From 1996 to 2000, he was a Resident at the Institute of Pathology at the University of Mainz, and then he became a Resident at the Clinic of Abdominal Surgery till 2001. From 2001 to 2003, he became a Scientist at the Max-Planck Institute for physiological and clinical research. From 2003 to 2008, he served as a Resident at the Institute of Pathology at the University of Regensburg. Since 2009, he has been serving at the Institute of Pathology Kaufbeuren. His fields of interest include developmental biology of physiological and pathological angiogenesis, tumor angiogenesis in experimental tumors and human primary tumors, therapeutic inhibition of receptor tyrosine kinases in experimental models and patients, and apoptosis, invasion, and chemoresistance in sarcomas and carcinomas. He is also a Reviewer of peer-reviewed journals such as Clinical Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer, Human Pathology, and Virchows Archiv.
Biography Updated on 17 March 2013